• SENSEX 75,157.26
    1,310.11 (+1.77%)
  • BANKNIFTY 51,002.35
    762.20 (+1.52%)
  • GMR Airports
    85.00 67.75(%)
  • Tata Motors
    612.65 1,179.05(%)
  • Dixon Technolog.
    14,330.00 19,149.80(%)
  • Reliance Industr
    1,222.45 1,608.95(%)
  • TCS
    3,205.25 3,060.25(%)
  • Infosys
    1,438.55 2,006.80(%)
  • Kalyan Jewellers
    516.90 794.60(%)
  • Mazagon Dock
    2,472.00 2,929.98(%)
  • HDFC Bank
    1,818.95 1,880.00(%)
  • Tata Steel
    134.95 184.60(%)
  • Cello World
    537.40 1,024.50(%)
  • Hind.Aeronautics
    4,140.95 5,675.00(%)
  • Nip. India Gold
    78.59 78.59(%)
  • Bharat Electron
    286.90 340.35(%)
  • Suzlon Energy
    53.90 86.04(%)
  • Hind. Unilever
    2,393.00 3,034.50(%)
  • Nippon ETF Liq.
    999.99 996.00(%)
  • St Bk of India
    759.95 912.10(%)
  • Eternal Ltd
    218.20 304.50(%)
  • Kaynes Tech
    5,152.30 7,824.95(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

Source Natural Foods & Herbal Supplements Ltd Pharmaceuticals - Indian - Bulk Drugs & Formln

  • Indian Private
  • BSE Code : 13792.0
  • ISIN : INE679C01027
180.20 -3 (-1.50%)
  • As on 14 Apr 2025 (EOD)

  • Today’s Low

    176.55

  • Today’s High

    191.95

  • Open

    191.95

  • Perv Close

    182.95

  • 52W Low

    78.00

  • 52W High

    269.75

Key Indicators

  • P/E(TTM)

    44.38

  • Mar.Cap (₹Cr.)

    115.99

  • Div & Yield %

    0.00

  • Book Value(₹)

    32.18

  • Debt-Equity Ratio

    -1.50

  • AGM Date

    11-Apr-2025

  • EPS

    4.06

  • P/E Ratio

    44.38

Financials Ratios

  • Debt-Equity Ratio

    -

  • Mar.Cap (₹Cr.)

    115.99

  • RONW (%)

    -

  • ROCE (%)

    -

Score Board

  • Equity (₹ in Cr.)

    6.44

  • BV (₹)

    32.20

  • Sales( ₹ in Cr.)

    27.30

  • NP (in Cr.)

    1.76

  • NP Var(%)

    -17.0

  • Div%

    0.0

  • CPS (₹)

    4.40

  • EPS (₹)

    2.70

  • Traded Value (₹ in Lakhs)

    115.99

  • 52 Week High

    269.75

  • 52 Week Low

    78.00

  • Price BSE

    180.0

  • Price NSE

    0.00

  • Market Capital( in Cr.)

    115.99

  • P/C Ratio

    41.30

  • P/E Ratio

    65.70

  • Price Vs.BV

    2.70

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar
INCOME :            
Sales Turnover 27.30 19.79 21.53 24.88 15.11 14.23
Excise Duty 0.00 0.00 0.00 0.00 1.52 1.42
Net Sales 27.30 19.79 21.53 24.88 13.59 12.81
Other Income 0.01 0.01 0.49 0.34 0.02 0.00
Stock Adjustments 1.34 0.40 0.62 -0.07 -0.33 -0.44
Total Income 28.65 20.20 22.64 25.15 13.28 12.37
EXPENDITURE :            
Raw Materials 18.12 10.25 10.05 9.84 4.53 4.37
Power and Fuel Cost 0.26 0.28 0.32 0.33 0.24 0.35
Employee Cost 2.88 3.14 3.86 2.54 2.29 2.13
Other Manufacturing Expenses 1.64 1.35 1.98 2.12 1.72 1.88
Selling and Administration Expenses 1.27 1.56 1.86 4.86 1.97 1.95
Miscellaneous Expenses 0.05 0.00 0.22 0.94 0.13 0.11
Employee Benefit Expenses 2.88 3.14 3.86 2.54 2.29 2.13
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 24.22 16.57 18.30 20.64 10.88 10.78
Operating Profit 4.43 3.62 4.34 4.50 2.41 1.59
Interest 0.21 0.27 0.24 0.10 0.23 0.20
Gross Profit 4.22 3.35 4.10 4.40 2.18 1.39
Depreciation 1.04 0.62 0.42 0.37 0.34 0.34
Profit Before Tax 3.18 2.73 3.68 4.03 1.84 1.05
Current Tax 1.12 0.61 0.91 1.32 0.43 0.24
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.32 0.01 0.34 -0.66 -0.22 -0.21
Reported Net Profit 1.74 2.12 2.43 3.37 1.64 1.03
Extraordinary Items -0.03 0.00 0.00 -0.01 0.00 0.00
Adjusted Net Profit 1.77 2.12 2.43 3.38 1.64 1.03
Adjustment below Net Profit 0.00 0.00 0.00 0.00 0.00 0.00
P & L Balance brought forward 10.14 8.02 5.59 2.21 1.22 0.19
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 0.00 0.00 0.00 0.00 0.64 0.00
P & L Balance carried down 11.88 10.14 8.02 5.59 2.21 1.22
Dividend 0.00 0.00 0.00 0.00 0.64 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 0.00 0.00 0.00 0.00 0.00 10.00
Dividend Per Share(Rs) 0.00 0.00 0.00 0.00 0.00 1.00
Earnings Per Share-Unit Curr 2.70 3.30 3.78 5.24 2.55 1.59
Earnings Per Share(Adj)-Unit Curr 2.70 3.30 3.78 5.24 2.55 1.59
Book Value 30.22 27.52 24.23 20.45 15.21 13.66
Book Value(Adj)-Unit Curr 30.22 27.52 24.23 20.45 15.21 13.66

Shareholding Pattern

  • Promoter Group

    74.37%

  • Public Share Holding

    25.63%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 4,786,891 74.37 4,786,891 1
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 0 0.00 0 0
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 4,786,891 74.37 4,786,891 1
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 0 0.00 0 0
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 0 0.00 0 0
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 0 0.00 0 0
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 0 0.00 0 0
2] Non Institution
Bodies Corporate 120,136 1.87 118,636 34
Clearing Members 0 0.00 0 0
Directors of their Relatives 36,015 0.56 36,015 2
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 207,427 3.22 207,277 31
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 414,303 6.44 414,303 8
Individuals holding nominal share capital up to Rs. 1 lakh 871,998 13.55 845,099 3,771
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 0 0.00 0 0
Others 161 0.00 3 2
Sub Total 1,650,040 25.63 1,621,333 3,848
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 6,436,931 100.00 6,408,224 3,849

Company Background

Source Natural Foods & Herbal Supplements LtdPharmaceuticals - Indian - Bulk Drugs & Formln

  • Source Natural Foods & Herbal Supplements Ltd
  • BSE Code : 13792.0
  • ISIN : INE679C01027

  • Incorporation Year

    1995

  • Registered Office

    201 2nd Floor Sumeru Towers
    54/46 39 Jayanagar 4th Block, Bangaluru,
    Karnataka-560041

  • Telephone

    91-80-26087733

  • FAX

    91-80-22449505

  • Chairman

    NARAYANAN NARASIMHAN

  • Managing Director

    Arvind Varchaswi N

  • Company Secretary

    Yash Jain

  • Auditor

    Srinaga & Giridharan

  • Face Value

    10

  • Listing

    BSE

  • Registrar

    Venture Capital & Corp. Inv.
    12-10-167 ,
    ,Bharath Nagar
    Mumbai - Hyderbad - 500018

Source Natural Foods & Herbal Supplements Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
Source Natural 180.20 27.30 27.30 44.60 17.73
Abbott India 29,578.60 6,097.18 5,848.91 47.10 44.71
Astrazeneca Phar 8,477.50 1,330.33 1,295.53 218.55 33.26
P & G Health Ltd 5,167.35 1,166.89 1,151.26 36.26 39.76
Glaxosmi. Pharma 2,747.05 3,530.73 3,407.25 54.62 44.44
Cipla 1,463.15 17,645.00 16,574.34 25.08 20.10
Amrutanjan Healt 634.70 437.58 421.23 37.20 20.84
Fermenta Biotec. 264.10 315.24 307.09 25.03 4.10
Guj. Themis Bio. 263.75 174.19 169.82 54.61 44.82
Bliss GVS Pharma 119.05 638.96 605.46 27.24 11.19
Ambalal Sarabhai 37.65 11.70 3.81 16.09 1.92